Oppenheimer issued a new reported on Envision Healthcare, predicting first quarter 2018 earnings of $0.51 per share, Stock News Times reports.
Here's what you should know:
1. Oppenheimer revised its predictions from the initial $0.49 per share.
2. In addition, Oppenheimer gave Envision an "outperform" rating and a $40 price target on the stock.
3. Several other analysts published predictions, as well. Robert Baird reissued its "buy" rating, with a price target of $55. Bank of America decreased their target from $72 to $60 while also setting a “buy” rating on the stock.
4. In total, nine companies issued a "buy" rating, eight a "hold" rating and one a "sell" rating. The consensus is a "hold" rating, and a price target of $41.